Literature DB >> 2883874

Beta-adrenergic blocker withdrawal.

W H Frishman.   

Abstract

Abrupt withdrawal of long-term beta-blocker therapy in patients with angina may be associated with unstable angina and myocardial infarction. It appears that an "overshoot" in heart rate from pretreatment values occurs, which increases myocardial oxygen demand. This increase in heart rate may be secondary to increased beta receptor numbers or increased receptor sensitivity. Another possible mechanism for the increased risk of myocardial infarction after beta-blocker withdrawal is increased platelet aggregability. Withdrawal reactions may be less severe with beta blockers that have partial agonist activity. In patients undergoing coronary artery bypass surgery, beta-blocker withdrawal reactions have also been observed. Maintenance of beta-blocker therapy on the morning of surgery appears to reduce this risk. Gradual withdrawal regimens in outpatients with angina may be associated with lower risk for a beta-blocker withdrawal reaction. The gradual withdrawal of beta blockers in hypertensive patients requires further study.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883874     DOI: 10.1016/0002-9149(87)90038-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Contemporary personalized β-blocker management in the perioperative setting.

Authors:  Adriana D Oprea; Xiaoxiao Wang; Robert Sickeler; Miklos D Kertai
Journal:  J Anesth       Date:  2019-10-21       Impact factor: 2.078

Review 2.  Drug deprescription-withdrawal risk, prevention, and treatment.

Authors:  Madison K Bangert; Gabriel M Aisenberg
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-12-20

Review 3.  N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study.

Authors:  Parag Goyal; Monika M Safford; Sarah N Hilmer; Michael A Steinman; Daniel D Matlock; Mathew S Maurer; Mark S Lachs; Ian M Kronish
Journal:  Br J Clin Pharmacol       Date:  2022-07-13       Impact factor: 3.716

4.  Ivabradine: the evidence of its therapeutic impact in angina.

Authors:  Guillaume Marquis-Gravel; Jean-Claude Tardif
Journal:  Core Evid       Date:  2008-06

5.  Effects of beta-blockers and Ca(2+)-antagonists on the response of the isolated working rat heart to adrenergic stimulants after cardioplegic arrest.

Authors:  P Hattingh; A Coetzee; I Harper; S Genade; A Lochner
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

6.  Discontinuation of beta-blockers and the risk of myocardial infarction in the elderly.

Authors:  Martina Teichert; Peter A G M de Smet; Albert Hofman; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.